(*) USA Approval Date: 2020. 09.09.
>Inhalation Powder
Company
Generic ICS: Fluticasone Furoate
Generic LABA: Vilanterol
Generic LAMA: Umeclidinium
ICS: Inhaled CorticoSteroid
LABA: Long-Acting β2-Agonist
LAMA: Long-Acting Muscarinic Antag
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2021. 12.28
Product Web-Site